Erlab, a US-based filtration and containment specialist, has expanded its production site in Nantes, France. The expansion has been an effort by Erland to support the company’s international growth.
The company currently operates in the US, France, and China. The family-owned business produces pioneering ductless fume hoods and developing innovative air filtration products.
With its production capacity now doubled, this infrastructure will enable Erlab to strengthen its position as a leader in the field of biological protection by offering more effective custom-made solutions for user safety.
This development goes hand in hand with an increased commitment to improve quality standards continuously while meeting the growing demand for advanced technologies.
With its production capacity now doubled, this state-of-the-art infrastructure will enable Erlab to strengthen its position as a leader in the field of biological protection
The project fully aligns with Erlab’s environmental policy. The building has been constructed following eco-design principles to minimise its carbon footprint and optimise energy efficiency.
The building also incorporates sustainable construction technologies that reflect the company’s vision for the future.
By adopting this new infrastructure, Erlab strengthens its commitment to industry that is more respectful of the environment.
The plant in Nantes will be better equipped to support production of the life sciences range through cutting-edge manufacturing processes.
Another milestone for the Erlab
Mark McLoughlin has also recently been appointed as Global President of Erlab.
This is a historic moment for the company, as it marks the first time in its 58-year history that a senior member of the scientific product community has taken on the role.
With McLoughlin at the helm, the company aims to strengthen its operations and drive its strategic direction forward.
McLoughlin brings four decades of experience in the healthcare industry.
Mark McLoughlin brings four decades of experience in the healthcare industry
During McLoughlin’s tenure as President of Avantor (formerly VWR), a supplier of products and services to research and production laboratories, he was responsible for the entire P&L of the Americas manufacturing, distribution, and services business.
Prior to this, the new Global President held leadership roles at Cardinal Health, Baxter, and Mallinckrodt, further strengthening his expertise in the sector.
“I am excited to join Erlab, a company that is deeply committed to innovation, growth, and customer satisfaction. I look forward to building upon the tremendous success of Erlab while enhancing our customer focus and company culture,” said Mark McLoughlin, President of Erlab.
As part of this leadership evolution, Erlab is also pleased to announce the promotion of Cédric Herry to VP of Innovation.
This development goes hand in hand with an increased commitment to improve quality standards
Actively involved in standardisation efforts, Cédric serves as Chairman of the ISO TC 336 standardisation committee for Laboratory Design. Since 2021, as Deputy General Manager, he has been instrumental in advancing laboratory safety at Erlab. He will further strengthen the company’s R&D strategy in his new role.
Additionally, Cyril Monnier has been promoted to General Manager of Europe. Leading Erlab’s European sales efforts since 2020 as Sales Director, his deep understanding of the market and commercial expertise will help support the company’s strategic development across Europe.
With these appointments, Erlab reinforces its commitment to continued expansion and leadership in laboratory safety.
Top image: Erlab's production site in Nantes, France